Form 4: Disc Medicine Executive Acquires Shares and Options in Recent Transactions

William Jacob Savage, Chief Medical Officer of Disc Medicine, reports acquisition of common stock and stock options.

Summary

• William Jacob Savage, the Chief Medical Officer of Disc Medicine, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 3, 2025, Savage acquired 4,233 shares of common stock at $2.65 per share and another 1,498 shares at the same price through the exercise of stock options.
• Additionally, on February 10, 2025, Savage acquired 24,000 restricted stock units (RSUs) and 36,000 stock options with an exercise price of $54.71.
• Following these transactions, Savage directly owns 70,136 shares of Disc Medicine common stock and 36,000 stock options.
• The RSUs vest in four annual installments starting February 15, 2026, while the new stock options vest monthly over four years starting March 10, 2025, both contingent upon continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by the CMO suggests confidence, but it's a routine transaction.

Positives

• The acquisition of shares and options by a key executive could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedules for the RSUs and stock options indicate a long-term commitment from the executive, with vesting occurring over the next several years contingent on continued service.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
• The vesting schedules for the RSUs and stock options are typical, designed to incentivize long-term performance and retention.
• The exercise price of $54.71 for the newly acquired options is a key metric, as it indicates the price at which the executive can purchase shares in the future, reflecting the company's growth expectations.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment, as they reflect insider confidence.
• Employees may view the executive's stock acquisitions as a positive sign for the company's future.

Key Dates